Download Compound Physiological concentration Reference Table 1

Compound
Physiological concentration
Reference
Table 1. Physiological concentrations of endogenous compounds studied
Amino Acids and Derivatives, Peptides
L-arginine
Carnosine (β-alanyl-l-
80 ± 20 µmol/L (plasma)
[1]
125 ± 5.5 µmol/L (plasma)
[2]
60 - 120 μmol/L (serum)
[3]
123.3 ± 44.6 μmol/L (plasma)
[4]
80–120 μmol/L (plasma)
[5]
40-120 μmol/L (plasma)
[6]
87 ± 3 μmol/L (plasma; Swedish population)
[7]
69 ± 3 μmol/L (plasma; Guatemalan population)
[7]
137 ± 8 μmol/L (plasma)
[8]
5 mmol/kg (human skeletal muscle)
[9]
60 - 130 μmol/L (serum)
[10]
115.2 ± 48.8 μmol/L (men; serum)
[11]
94.6 ± 39.3 μmol/L (women; serum)
[11]
52 ± 11 μmol/L (plasma)
[1]
25.2 ± 1.5 μmol/L (erythrocyte)
[12]
239 ± 40 μmol/L (plasma)
[13]
100-330 μmol/L (plasma)
[6]
248 ± 13 μmol/L (plasma; Swedish population)
[7]
210 ± 17 μmol/L (plasma; Guatemalan population)
[7]
514.7 ± 33.1 μmol/L (erythrocyte)
[12]
1.6 ± 0.5 μmol/L (plasma)
[14]
2.4 ± 1.0 μmol/L (plasma)
[15]
6.75 ± 0.47 μmol/g Hb (erythrocytes)
[12]
8.46 ± 0.175 μmol/g Hb (erythrocytes)
[16]
0.11 ± 0.05 μmol/L (plasma)
[14]
0.2 ± 0.2 μmol/L (plasma)
[15]
0.0132 ± 0.004 μmol/gHb (erythrocytes)
[16]
82 ± 10 μmol/L (plasma)
[1]
histidine)
Creatinine
Cysteine
Glycine
GSH
GSSG
Histidine
*This range is considered normal by the American Medical Association
30-150 μmol/L (plasma)
[6]
87 ± 6 μmol/L (plasma; Swedish population)
[7]
87 ± 3 μmol/L (plasma; Guatemalan population)
[7]
188 ± 32 μmol/L (plasma)
[1]
100-300 μmol/L (plasma)
[6]
195 ± 9 μmol/L (plasma; Swedish population)
[7]
150 ± 8 μmol/L (plasma; Guatemalan population)
[7]
Melatonin
0.042 ± 0.03 nmol/L (plasma)
[17]
Methionine
25 ± 4 μmol/L (plasma)
[1]
25 ± 1 μmol/L (plasma; Swedish population)
[7]
24 ± 1 μmol/L (plasma; Guatemalan population)
[7]
114 ± 19 µmol/L (plasma)
[1]
90-290 μmol/L (plasma)
[6]
114 ± 4 μmol/L (plasma; Swedish population)
[7]
102 ± 5 μmol/L (plasma; Guatemalan population)
[7]
44 ± 7 μmol/L (plasma)
[18]
73 μmol/L ± 14.9 (serum) H
[6]
30-80 μmol/L (plasma)
[7]
25 ± 1 μmol/L (plasma; Swedish population)
[7]
24 ± 1 μmol/L (plasma; Guatemalan population)
[7]
59 ± 12 μmol/L (plasma)
[1]
35 -102 μmol/L (plasma)
[19]
39- 89 μmol/L (plasma)
[20]
30-120 μmol/L(plasma)
[6]
60 ± 4μmol/L (plasma; Swedish population)
[7]
54 ± 2 μmol/L (plasma; Guatemalan population)
[7]
5300 ± 1080 µmol/L (men; plasma)
[21]
4800 ± 1200 µmol/L (women; plasma)
[21]
6500 ± 2500 (µmol/L) (plasma; Guatemalan
[7]
Lysine
Serine
Tryptophan
Tyrosine
Urea
population)
Organic acids
Oxaloacetic acid
0.34 ± 0 02 µmol/L (blood)
[22]
Pantothenic acid
Pyruvic acid
Uric acid
1.1 - 12 µmol/L (blood)
[23]
4.79 – 11.05 µmol/L (blood)
[24]
29 ± 23 µmol/L (plasma)
[25]
33 ± 14 µmol/L (erythrocytes)
[26]
380 μmol/L (plasma)
[27]
214- 494 µmol/L (plasma)
*
119-375 µmol/L (women; serum)
[28]
155-404 µmol/L (men; serum)
[28]
0.074 ± 0.016 μmol/g Hb (women; erythrocytes)
[29]
0.083 ± 0.026 μmol/g Hb (men; erythrocytes)
[29]
Polyamines
Spermidine
Spermine
0.32 ± 0.07 µmol/L (serum)
[30]
72.9 ± 34.9 nmol/L (plasma)
[31]
14.7 (10–24) μmol/L(erythrocytes) H
[32]
0.039 ± 0.029 µmol/L (plasma)
[33]
30.7 ± 39.5 nmol/L (plasma)
[31]
B-group vitamins
Vit B1
0.064 ± 0.12 μmol/L (plasma)
[34]
Vit B2
0.0027 – 0.0425 μmol/L (plasma)
[35]
0.018 μmol/L (plasma)
[36]
0.0757 μmol/L (plasma)
[37]
Vit B6
Nucleotides
AMP
0.067 ± 0.02 μmol/L (human skeletal muscles)
[38]
ATP
1.02 ± 0.09 µmol/L (plasma)
[39]
NAD
24.3 µmol/L (whole blood)
[40]
References
[1] J. Le Boucher, C. Charret, C. Coudray-Lucas, J. Giboudeau, L. Cynober, Amino acid
determination in biological fluids by automated ion-exchange chromatography:
performance of Hitachi L-8500A, Clin. Chem. 43 (1997) 1421-1428.
[2] H. Hanssen, T.M. Brunini, M. Conway, A.P. Banning, N.B. Robert, G.E. Mann, J.C. Ellory,
A.C. Mendes Ribeiro, Increased L-arginine transport in human erythrocytes in chronic
heart failure, Clin. Sci. (Lond). 94 (1998) 43-48.
[3] C.V. Suschek, O. Schnorr, K. Hemmrich, O. Aust, L.O. Klotz, H. Sies, V. Kolb-Bachofen,
Critical role of L-arginine in endothelial cell survival during oxidative stress, Circulation
107 (2003) 2607-2614.
[4] T.S. Alvares, C.A. Conte-Junior, J.T. Silva, V.M. Paschoalin, Acute L-Arginine
supplementation does not increase nitric oxide production in healthy subjects, Nutr.
Metab. (Lond). 9 (2012) 54.
[5] S.M. Morris Jr, Arginine metabolism: boundaries of our knowledge, J. Nutr. 137 (2007)
1602S-1609S.
[6] K.J. Kingsbury, L. Kay, M. Hjelm, Contrasting plasma free amino acid patterns in elite
athletes: association with fatigue and infection, Br. J. Sports Med. 32 (1998) 25–33.
[7] P. Klassen, P. Fürst, C. Schulz, M. Mazariegos, N.W. Solomons, Plasma free amino acid
concentrations in healthy Guatemalan adults and in patients with classic dengue, Am. J.
Clin. Nutr. 73 (2001) 647-652.
[8] M.B. Moss, T.M. Brunini, R. Soares De Moura, L.E. Novaes Malagris, N.B. Roberts, J.C.
Ellory, G.E. Mann, A.C. Mendes Ribeiro, Diminished L-arginine bioavailability in
hypertension, Clin. Sci. (Lond). 107 (2004) 391-397.
[9] A. Baguet, Important role of muscle carnosine in rowing performance, J. Appl. Physiol. 109
(2010) 1096–1101.
[10] I. Sadowska-Bartosz, S. Galiniak, G. Bartosz, M. Rachel M, Oxidative modification of
proteins in pediatric cystic fibrosis with bacterial infections, Oxid. Med. Cell. Longev.
2014 (2014) 389629.
[11] J.G. Wang, J.A. Staessen, R.H. Fagard, W.H. Birkenhäger, L. Gong, L. Liu, Prognostic
significance of serum creatinine and uric acid in older Chinese patients with isolated
systolic hypertension, Hypertension 37 (2001) 1069-1074.
[12] R.V. Sekhar, S.V. McKay, S.G. Patel, A.P. Guthikonda, V.T. Reddy, A.
Balasubramanyam, F. Jahoor, Glutathione synthesis is diminished in patients with
uncontrolled diabetes and restored by dietary supplementation with cysteine and glycine,
Diabetes Care 34 (2011) 162-167.
[13] A.E. Evins, S.M. Fitzgerald, L. Wine, R. Rosselli, D.C. Goff, Placebo-controlled trial of
glycine added to clozapine in schizophrenia, Am. J. Psychiatry 157 (2000) 826–828.
[14] S. Ashfaq, J.L. Abramson, D.P. Jones, S.D. Rhodes, W.S. Weintraub, W.C. Hooper, V.
Vaccarino, D.G. Harrison, A.A.Quyyumi, The relationship between plasma levels of
oxidized and reduced thiols and early atherosclerosis in healthy adults, J. Am. Coll.
Cardiol. 47 (2006) 1005-1011.
[15] S.E. Moriarty, J.H. Shah, M. Lynn, S. Jiang, K. Openo, D.P. Jones, P. Sternberg P,
Oxidation of glutathione and cysteine in human plasma associated with smoking, Free
Radic. Biol. Med. 35 (2003) 1582-1588.
[16] D. Giustarini, I. Dalle-Donne, A. Milzani, P. Fanti, R. Rossi R, Analysis of GSH and GSSG
after derivatization with N-ethylmaleimide, Nat. Protoc. 8 (2013) 1660-1669.
[17] S. Caglayan, M. Ozata, G. Ozisik, M. Turan, E. Bolu, C. Oktenli, N. Arslan, K. Erbil, D.
Gul, I.C. Ozdemir, Plasma melatonin concentration before and during testosterone
replacement in Klinefelter's syndrome: relation to hepatic indolamine metabolism and
sympathoadrenal activity, J. Clin. Endocrinol. Metab. 86 (2001) 738-743.
[18] B. Widner, E.R. Werner, H. Schennach, H. Wachter, D. Fuchs, Simultaneous measurement
of serum tryptophan and kynurenine by HPLC, Clin. Chem. 43 (1997) 2424-2426.
[19] M.D. Armstrong, U. Stave, A study of plasma free amino acid levels. II. Normal values
for children and adults, Metabolism 22 (1973) 561-569.
[20] S.C. Grünert, C.M. Brichta, A. Krebs, H.W. Clement, R. Rauh, C. Fleischhaker, K.
Hennighausen, J.O. Sass, K.O. Schwab, Diurnal variation of phenylalanine and tyrosine
concentrations in adult patients with phenylketonuria: subcutaneous microdialysis is no
adequate tool for the determination of amino acid concentrations, Nutr. J. 12 (2013) 60.
[21] W.E. Waters, W.J. Greene, J.W. Keyser, Plasma urea concentrations in the general
population: comparison with 'hospital normal values', Postgrad. Med. J. 43 (1967) 695–
700.
[22] A. Laplante, B. Comte, C. Des Rosiers, Assay of blood and tissue oxaloacetate and alphaketoglutarate by isotope dilution gas chromatography-mass spectrometry, Anal.
Biochem. 224 (1995) 580-587.
[23] C.T. Wittwer, C. Schweitzer, J. Pearson, W.O. Song, C.T. Windham, B.W. Wyse, R.G.
Hansen, Enzymes for liberation of pantothenic acid in blood: use of plasma pantetheinase,
Am. J. Clin. Nutr. 50 (1989) 1072-1078.
[24] S.H. Cohenour, D.H. Calloway, Blood, urine, and dietary pantothenic acid levels of
pregnant teenagers, Am. J. Clin. Nutr. 25 (1972) 512-517.
[25] H. Okada, S. Araga, T. Takeshima, K. Nakashima, Plasma lactic acid and pyruvic acid
levels in migraine and tension-type headache, Headache 38 (1998) 39-42.
[26] S.F. Travis, A.D. Morrison, R.S. Clements Jr, A.I. Winegrad, F.A. Oski, Metabolic
alterations in the human erythrocyte produced by increases in glucose concentration. The
role of the polyol pathway, J. Clin. Invest. 50 (1971) 2104-2112.
[27] E.P. de Oliveira, R.C. Burini, High plasma uric acid concentration: causes and
consequences, Diabetol. Metab. Syndr. 4 (2012) 12.
[28] A. Hesse, H.G. Tiselius, A. Jahnen, Urinary Stones: Diagnosis, treatment, and prevention
of recurrence, second ed., S. Karger AG, Basel, Switzerland, 2002.
[29] R. Kanďár, X. Štramová, P. Drábková, J. Křenková, A monitoring of allantoin, uric acid,
and malondialdehyde levels in plasma and erythrocytes after ten minutes of running
activity, Physiol. Res. 63 (2014) 753-762.
[30] L.J. Marton, D.H. Russell, C.C. Levy, Measurement of putrescine, spermidine, and
spermine in physiological fluids by use of an amino acid analyzer, Clin. Chem. 19 (1973)
923-926.
[31] K. Igarashi, S. Ueda, K. Yoshida, K. Kashiwagi, Polyamines in renal failure, Amino
Acids 31 (2006) 477-483.
[32] G. Seghieri, R. Anichini, M. Ciuti, A. Gironi, F. Bennardini, F. Franconi, Raised
erythrocyte polyamine levels in non-insulin-dependent diabetes mellitus with great vessel
disease and albuminuria, Diabetes Res. Clin. Pract. 37 (1997) 15-20.
[33] H. Desser, G. Kleinberger, J. Kläring, Plasma polyamine levels in liver insufficiency, J.
Clin. Chem. Clin. Biochem. 19 (1981) 159-164.
[34] P.J. Thornalley, R. Babaei-Jadidi, H. Al Ali, N. Rabbani, A. Antonysunil, J. Larkin, A.
Ahmed, G. Rayman, C.W. Bodmer, High prevalence of low plasma thiamine
concentration in diabetes linked to a marker of vascular disease, Diabetologia 50 (2007)
2164–2170.
[35] S. Hustad, P.M. Ueland, J. Schneede, Quantification of riboflavin, flavin mononucleotide,
and flavin adenine dinucleotide in human plasma by capillary electrophoresis and laserinduced fluorescence detection, Clin. Chem. 45 (1999) 862-868.
[36] Ø. Midttun, S. Hustad, J. Schneede, S.E. Vollset, P.M. Ueland, Plasma vitamin B-6 forms
and their relation to transsulfuration metabolites in a large, population-based study, Am.
J. Clin. Nutr. 86 (2007) 131-8.
[37] A.C. Peeters, B.A. van Landeghem, S.J. Graafsma, S.E. Kranendonk, A.R. Hermus, H.J.
Blom HJ, M. den Heijer, Low vitamin B6, and not plasma homocysteine concentration,
as risk factor for abdominal aortic aneurysm: a retrospective case-control study, J. Vasc.
Surg. 45 (2007) 701-705.
[38] Y. Hellsten, D. Maclean, G. Rådegran, B. Saltin, J. Bangsbo, Adenosine concentrations in
the interstitium of resting and contracting human skeletal muscle, Circulation 98 (1998)
6-8.
[39] A.S. Lader, A.G. Prat, G.R. Jackson, K.L. Chervinsky, A. Lapey, T.B. Kinane, H.F.
Cantiello, Increased circulating levels of plasma ATP in cystic fibrosis patients, Clin.
Physiol. 20 (2000) 348-353.
[40] P.I. Creeke, F. Dibari, E. Cheung, T. van den Briel, E. Kyroussis, A.J. Seal, Whole blood
NAD and NADP concentrations are not depressed in subjects with clinical pellagra, J.
Nutr. 137 (2007) 2013-2017.